Canada's Drug Agency Collaborative Workspaces
All materials must adhere to the content, format, and organization specified in the Procedure and Submission Guidelines for the Canada's Drug Agency Common Drug Review and all applicable Canada's Drug Agency Pharmaceutical Review Updates.
To submit and contribute drug review information you must be registered with the Canada's Drug Agency Collaborative Workspaces. If you are a sponsor or designated consultant who intends to file a CDR application you may register by submitting completing the Registration Form.
If you have already registered, you may log in.
Registration
Before submitting to the Canada's Drug Agency, sponsors or designated consultants must be registered with CDR. This will provide access to a secure submit and contribute page and enable the electronic delivery of documents to Canada's Drug Agency.
Last Updated : November 27, 2017